GLOFITAMAB for Diffuse large b-cell lymphoma refractory: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 55 adverse event reports in the FDA FAERS database where GLOFITAMAB was used for Diffuse large b-cell lymphoma refractory.

Most Reported Side Effects for GLOFITAMAB

Side Effect	Reports	%	Deaths	Hosp.
Cytokine release syndrome	415	37.2%	102	239
Disease progression	183	16.4%	78	39
Off label use	129	11.6%	37	44
Death	125	11.2%	125	12
Neutropenia	109	9.8%	18	59
Pyrexia	78	7.0%	15	46
Febrile neutropenia	69	6.2%	2	55
Covid-19	62	5.6%	11	31
Drug ineffective	53	4.8%	10	10
Immune effector cell-associated neurotoxicity syndrome	45	4.0%	17	16
Infection	44	3.9%	28	12
Pneumonia	41	3.7%	11	20
Sepsis	29	2.6%	15	14
Septic shock	27	2.4%	20	15
Alanine aminotransferase increased	26	2.3%	2	15